| Style | Citing Format |
|---|---|
| MLA | Feily A, Rasaii S, Nilforoushzadeh MA. "Rebamipide As a Novel Addition to the Antivitiligo Ordnance." International Journal of Clinical Pharmacology and Therapeutics, vol. 53, no. 12, 2015, pp. 1035-1036. |
| APA | Feily A, Rasaii S, Nilforoushzadeh MA (2015). Rebamipide As a Novel Addition to the Antivitiligo Ordnance. International Journal of Clinical Pharmacology and Therapeutics, 53(12), 1035-1036. |
| Chicago | Feily A, Rasaii S, Nilforoushzadeh MA. "Rebamipide As a Novel Addition to the Antivitiligo Ordnance." International Journal of Clinical Pharmacology and Therapeutics 53, no. 12 (2015): 1035-1036. |
| Harvard | Feily A, Rasaii S, Nilforoushzadeh MA (2015) 'Rebamipide As a Novel Addition to the Antivitiligo Ordnance', International Journal of Clinical Pharmacology and Therapeutics, 53(12), pp. 1035-1036. |
| Vancouver | Feily A, Rasaii S, Nilforoushzadeh MA. Rebamipide As a Novel Addition to the Antivitiligo Ordnance. International Journal of Clinical Pharmacology and Therapeutics. 2015;53(12):1035-1036. |
| BibTex | @article{ author = {Feily A and Rasaii S and Nilforoushzadeh MA}, title = {Rebamipide As a Novel Addition to the Antivitiligo Ordnance}, journal = {International Journal of Clinical Pharmacology and Therapeutics}, volume = {53}, number = {12}, pages = {1035-1036}, year = {2015} } |
| RIS | TY - JOUR AU - Feily A AU - Rasaii S AU - Nilforoushzadeh MA TI - Rebamipide As a Novel Addition to the Antivitiligo Ordnance JO - International Journal of Clinical Pharmacology and Therapeutics VL - 53 IS - 12 SP - 1035 EP - 1036 PY - 2015 ER - |